BXP, Inc. (NYSE: BXP) is the largest publicly traded developer, owner, and manager of premier workplaces in the United States, concentrated in six dynamic gateway markets - Boston, Los Angeles, New York, San Francisco, Seattle, and Washington, DC. BXP has delivered places that power progress for our clients and communities for more than 50 years. BXP is a fully integrated real estate company, organized as a real estate investment trust (REIT). Including properties owned by unconsolidated joint ventures, BXP's portfolio totals 53.3 million square feet and 185 properties, including seven properties under construction/redevelopment.

BXP Inc.

In a report released today, Ronald Kamdem from Morgan Stanley reiterated a Hold rating on BXP, with a price target of $60.00. Kamdem covers the Rea...

Morgan Stanley Sticks to Its Hold Rating for BXP (BXP)

Botanix Pharmaceuticals Limited ( ($AU:BOT) ) has provided an update. Botanix Pharmaceuticals has announced its participation in the annual Euroz H...

Botanix Showcases FDA-Approved Hyperhidrosis Drug at Euroz Hartleys Conference

An announcement from Botanix Pharmaceuticals Limited ( ($AU:BOT) ) is now available. Botanix Pharmaceuticals has updated investors on its proposed ...

Botanix Revises Securities Purchase Plan Timetable and Sets Approval Date

Botanix Pharmaceuticals Limited ( ($AU:BOT) ) has issued an update. Botanix Pharmaceuticals has updated investors on its plans for a new issue of s...

Botanix updates timetable for share purchase plan securities issue

Botanix Pharmaceuticals Limited ( ($AU:BOT) ) just unveiled an announcement. Botanix Pharmaceuticals has opened its security purchase plan as part ...

Botanix Opens Underwritten Security Purchase Plan to Fund Dermatology Growth

BXP ( ($BXP) ) just unveiled an update. On March 6, 2026, BXP, Inc. and its operating partnership filed new automatic shelf registration statements...

BXP Launches $1 Billion At-The-Market Equity Program

The latest update is out from BXP ( ($BXP) ). On March 6, 2026, BXP, Inc. and its operating partnership filed new automatic shelf registration stat...

Market Cap	$10.86B	P/E Ratio	7.41
52W High	$79.33	52W Low	$49.72
Div Yield	280.0%	Payout Ratio	260.0%
EPS Growth 3Y	0.0%	52W Position	7.0%
Overall Score	47	Value Score	65
Quality Score	42	Technical Score	36

EPS Current Est	$6.99	EPS Next Est	$7.2
EPS Growth Est	+3.0%	DPS Growth 3Y	0.0%

	A	B	C	D
1	Symbol	Price	Change	Volume
2	BXP	$51.78	0.00%	2.00M
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	BXP	$51.78	0%	2.00M
3
4
5
6

BXP

BXP

Key Metrics Overview

Growth Analysis

Revenue (5Y)

EBITDA (5Y)

Get BXP Inc. Data in Excel

Get BXP Inc. Data in Excel